Mayo Clinic is gearing up to delve into the realm of "digital omics," integrating patients' genetic information directly into electronic health records (EHRs) to pave the way for more personalized treatment approaches.
This digital initiative forms a crucial component of the health system's broader "omics" strategy, which encompasses rare diseases, genetic testing, and cutting-edge technologies aimed at scrutinizing cell functions. The endeavor heavily leans on artificial intelligence (AI) to sift through vast datasets and extract valuable insights.
Dr. Konstantinos Lazaridis, the Carlson and Nelson Endowed Executive Director for Mayo Clinic's Center for Individualized Medicine, emphasized the transformative potential of this era, wherein the synergy of big data and AI presents unparalleled opportunities for disease prevention and care enhancement.
The implementation of digital omics involves the seamless integration of this wealth of data into clinicians' EHRs, including insights gleaned from the extensive Tapestry genomics study, facilitated by robust data governance and standardized definitions. Additionally, Mayo Clinic is actively developing AI algorithms designed to pinpoint primary care patients who stand to benefit from genetic testing, thereby optimizing healthcare delivery.
Click here to read the original news story.